Docmode Health Technologies Ltd
Incorporated in 2017, Docmode Health Technologies Ltd is in the business of
offering integrated learning solutions
through online and offline learning
models for healthcare professionals[1]
- Market Cap ₹ 38.6 Cr.
- Current Price ₹ 123
- High / Low ₹ 123 / 36.9
- Stock P/E
- Book Value ₹ 26.6
- Dividend Yield 0.00 %
- ROCE -0.29 %
- ROE -21.7 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
Cons
- Company has low interest coverage ratio.
- Company has a low return on equity of 0.59% over last 3 years.
- Promoters have pledged or encumbered 61.2% of their holding.
- Company's cost of borrowing seems high
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Consumer Discretionary Consumer Services Other Consumer Services E-Learning
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 6.94 | 7.10 | 12.42 | 32.88 | 39.93 | 41.71 | |
| 6.55 | 6.23 | 10.53 | 29.14 | 38.05 | 42.39 | |
| Operating Profit | 0.39 | 0.87 | 1.89 | 3.74 | 1.88 | -0.68 |
| OPM % | 5.62% | 12.25% | 15.22% | 11.37% | 4.71% | -1.63% |
| 0.00 | 0.00 | 0.01 | 0.10 | 0.14 | 0.93 | |
| Interest | 0.01 | 0.19 | 0.38 | 1.13 | 1.66 | 1.92 |
| Depreciation | 0.05 | 0.04 | 0.02 | 0.02 | 0.02 | 0.30 |
| Profit before tax | 0.33 | 0.64 | 1.50 | 2.69 | 0.34 | -1.97 |
| Tax % | -6.06% | 14.06% | 38.67% | 27.51% | 44.12% | 3.05% |
| 0.34 | 0.55 | 0.92 | 1.95 | 0.19 | -2.03 | |
| EPS in Rs | 8.50 | 0.60 | -6.46 | |||
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 43% |
| 3 Years: | 50% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -1168% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 50% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 8% |
| 3 Years: | 1% |
| Last Year: | -22% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 0.01 | 2.29 | 3.14 | 3.14 |
| Reserves | -0.10 | 0.46 | 1.38 | 1.18 | 7.23 | 5.21 |
| 0.02 | 1.06 | 4.84 | 8.48 | 9.18 | 6.82 | |
| 1.96 | 4.14 | 3.85 | 5.06 | 10.60 | 24.14 | |
| Total Liabilities | 1.89 | 5.67 | 10.08 | 17.01 | 30.15 | 39.31 |
| 0.15 | 0.16 | 0.50 | 2.07 | 0.97 | 1.22 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 8.50 | 11.60 |
| Investments | 0.00 | 0.10 | 1.25 | 1.20 | 1.26 | 1.29 |
| 1.74 | 5.41 | 8.33 | 13.74 | 19.42 | 25.20 | |
| Total Assets | 1.89 | 5.67 | 10.08 | 17.01 | 30.15 | 39.31 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 0.17 | -0.50 | -2.05 | -0.83 | 4.51 | 6.68 | |
| -0.20 | -0.13 | -1.52 | -1.57 | -7.55 | -3.67 | |
| 0.01 | 0.84 | 3.41 | 2.65 | 5.76 | -4.28 | |
| Net Cash Flow | -0.03 | 0.21 | -0.17 | 0.25 | 2.72 | -1.27 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 0.53 | 69.92 | 112.26 | 92.03 | 104.85 | 80.86 |
| Inventory Days | 120.77 | 668.83 | 501.37 | |||
| Days Payable | 60.38 | 511.82 | 322.88 | |||
| Cash Conversion Cycle | 60.91 | 226.93 | 290.75 | 92.03 | 104.85 | 80.86 |
| Working Capital Days | -22.62 | 30.33 | 92.28 | 50.07 | 11.61 | -54.17 |
| ROCE % | 113.70% | 48.45% | 42.02% | 12.70% | -0.29% |
Documents
Announcements
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
10 October 2025 - RTA certifies Regulation 74(5) not applicable; no rematerialisation requests for quarter ended 30 Sept 2025.
-
Updates
10 October 2025 - Reconciliation of share capital audit report for quarter ended 30 September 2025 submitted.
-
Shareholders meeting
30 September 2025 - AGM on 30 Sep 2025: adopted FY2025 financials; reappointed director; approved related-party transactions and director remuneration.
-
Trading Window
24 September 2025 - Trading window closed from 01 Oct 2025 until 48 hours after H1 FY2025 results declaration.
-
Outcome of Board Meeting
29 August 2025 - Reappointment of Paulson Paul from 30 Sep 2025 for one year; remuneration approval for Hans Albert Lewis Jan 2026–Dec 2027.
Business Overview:[1]
DocMode is a healthcare technology company providing integrated learning solutions, cutting-edge practice tools, and comprehensive research platforms. DocMode's comprehensive product suite includes the DocMode LERN platform, which provides an online learning environment with resources and networking for 3.50 Lac+ healtcare professionals. Under this platform, company offers certification programs, national and international speaker programs, live inter active case-based quiz programs, and the Gapsule platform to bridge knowledge
gaps between the pharmaceutical industry, medical practitioners, and healthcare providers